Prognostic value of body mass index in Korean patients with renal cell carcinoma
- PMID: 20006879
- DOI: 10.1016/j.juro.2009.10.004
Prognostic value of body mass index in Korean patients with renal cell carcinoma
Abstract
Purpose: Whether body mass index is a prognostic factor in patients with renal cell carcinoma continues to be debated. We investigated the association between body mass index, and clinical/pathological features and prognosis in a large cohort of Korean patients with renal cell carcinoma.
Materials and methods: The medical records of 1,017 patients with renal cell carcinoma who underwent curative surgery between 1988 and 2006 were reviewed. Mean followup was 76.9 months. We analyzed the association of body mass index at surgery with tumor pathological features, and its associations with cancer specific survival and overall survival were evaluated using the Kaplan-Meier method and Cox regression models. Additional survival analysis was performed in a subgroup of 897 patients with T1-4N0M0 disease.
Results: Of the 1,017 patients 363 (35.7%), 526 (51.7%) and 128 (12.6%) had a body mass index of less than 23 (normal), 23 to 27.5 (overweight) and 27.5 or greater (obese) kg/m(2), respectively. Overweight and obese patients had less aggressive tumors, such as less lymph node and/or distant metastases (p = 0.001), low pathological T stage (p = 0.047) and low Fuhrman grade (p = 0.033) vs normal weight patients. In terms of cancer specific survival and overall survival multivariate analysis showed that overweight (p = 0.040 and p = 0.047, respectively) and obese (p = 0.024 and p = 0.010, respectively) patients had good survival rates compared to those with a body mass index in the normal range in the cohort (T1-4NallMall) groups. In addition, overweight (p = 0.022 and p = 0.029, respectively) and obese (p = 0.009 and p = 0.002, respectively) status was significantly associated with cancer specific and overall survival in the T1-4N0M0 groups.
Conclusions: Our findings suggest that overweight and obese Korean patients with renal cell carcinoma have more favorable pathological features and a better prognosis than those with a normal body mass index.
Copyright 2010 American Urological Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.Urology. 2006 Oct;68(4):741-6. doi: 10.1016/j.urology.2006.05.024. Urology. 2006. PMID: 17070345
-
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.J Urol. 2002 Jul;168(1):56-60. J Urol. 2002. PMID: 12050492
-
The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.BJU Int. 2008 May;101(10):1243-6. doi: 10.1111/j.1464-410X.2007.07375.x. Epub 2008 Feb 5. BJU Int. 2008. PMID: 18261150
-
Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature.Arch Esp Urol. 2002 Oct;55(8):969-75. Arch Esp Urol. 2002. PMID: 12455292 Review.
-
Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors.Urology. 2004 Jan;63(1):46-50. doi: 10.1016/j.urology.2003.08.009. Urology. 2004. PMID: 14751346 Review.
Cited by
-
Association of body mass index with mortality and postoperative survival in renal cell cancer patients, a meta-analysis.Oncotarget. 2018 Jan 12;9(17):13959-13970. doi: 10.18632/oncotarget.24210. eCollection 2018 Mar 2. Oncotarget. 2018. PMID: 29568408 Free PMC article.
-
Renal cell carcinoma survival and body mass index: a dose-response meta-analysis reveals another potential paradox within a paradox.Int J Obes (Lond). 2016 Dec;40(12):1817-1822. doi: 10.1038/ijo.2016.171. Epub 2016 Sep 30. Int J Obes (Lond). 2016. PMID: 27686524 Review.
-
Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial.Cancer Metab. 2021 Apr 6;9(1):15. doi: 10.1186/s40170-021-00251-y. Cancer Metab. 2021. PMID: 33823929 Free PMC article.
-
Lung cancer and obesity: A contentious relationship (Review).Oncol Rep. 2024 Nov;52(5):158. doi: 10.3892/or.2024.8817. Epub 2024 Nov 4. Oncol Rep. 2024. PMID: 39497438 Free PMC article. Review.
-
Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma.Sci Rep. 2022 Oct 6;12(1):16718. doi: 10.1038/s41598-022-20877-2. Sci Rep. 2022. PMID: 36202890 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical